ADURO BIOTECH INC's ticker is ADRO and the CUSIP is 00739L101. A total of 94 filers reported holding ADURO BIOTECH INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,951,000 | +5.5% | 802,749 | +0.3% | 0.01% | 0.0% |
| Q2 2020 | $1,849,000 | +6.5% | 800,599 | +26.3% | 0.01% | -20.0% |
| Q1 2020 | $1,736,000 | +146.6% | 633,865 | +6.3% | 0.01% | +233.3% |
| Q4 2019 | $704,000 | +110.1% | 596,284 | +88.6% | 0.00% | +200.0% |
| Q3 2019 | $335,000 | -5.6% | 316,186 | +37.0% | 0.00% | -50.0% |
| Q2 2019 | $355,000 | -63.7% | 230,752 | -6.2% | 0.00% | -50.0% |
| Q1 2019 | $979,000 | +566.0% | 245,947 | +341.8% | 0.00% | +300.0% |
| Q4 2018 | $147,000 | +14600.0% | 55,674 | +70373.4% | 0.00% | – |
| Q3 2016 | $1,000 | -100.0% | 79 | -100.0% | 0.00% | -100.0% |
| Q2 2016 | $2,500,000 | +261.8% | 221,028 | +310.2% | 0.01% | +333.3% |
| Q1 2016 | $691,000 | +34450.0% | 53,888 | +68112.7% | 0.00% | – |
| Q4 2015 | $2,000 | 0.0% | 79 | 0.0% | 0.00% | – |
| Q3 2015 | $2,000 | 0.0% | 79 | 0.0% | 0.00% | – |
| Q2 2015 | $2,000 | – | 79 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 2,106,734 | $40,807,000 | 12.39% |
| Rock Springs Capital Management LP | 415,000 | $8,039,000 | 0.65% |
| CLOUGH CAPITAL PARTNERS L P | 592,697 | $11,481,000 | 0.50% |
| NJ State Employees Deferred Compensation Plan | 53,300 | $1,032,000 | 0.22% |
| Orbimed Advisors | 1,065,522 | $20,639,000 | 0.21% |
| Point72 Asset Management, L.P. | 845,700 | $16,381,000 | 0.13% |
| LMCG INVESTMENTS, LLC | 244,382 | $4,734,000 | 0.10% |
| EverPoint Asset Management, LLC | 150,000 | $2,906,000 | 0.08% |
| M&T BANK CORP | 566,560 | $10,974,000 | 0.08% |
| GLOBEFLEX CAPITAL L P | 15,200 | $294,000 | 0.06% |